Every Form 4 that Crocs Inc (CROX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CROX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CROX filings page.
Crocs, Inc. reported that a trust associated with Chief Executive Officer Andrew Rees sold a total of 30,000 shares of common stock on August 7 and 10, 2026 in open-market transactions. The weighted-average sale prices came from ranges between $136.78 and $140.05 per share. A separate entry shows Rees holding 570,179 shares of common stock directly as of August 7, 2026.
Crocs, Inc. CEO Andrew Rees exercised 200,000 employee stock options on August 4, 2026 at an exercise price of $6.98 per share, receiving 200,000 shares of common stock. The issuer withheld 105,610 shares at $141.19 per share to cover the exercise price and tax obligations. A family trust for which Rees is trustee holds 743,293 shares of Crocs common stock with voting and investment power, and the transactions were not made under a Rule 10b5-1 trading plan.
FRASCH RONALD reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Ronald Frasch received an equity grant of common stock as part of his board compensation. He was awarded 1,252 shares of common stock on June 9, 2026 at a stated price of $0.00 per share, reflecting a non-cash compensation award.
According to the filing, this represents the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan. Following this grant, Frasch directly holds a total of 76,180 shares of Crocs common stock.
Bickley Ian reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. disclosed that director Ian Bickley received an equity award of common stock. On June 9, 2026, he was granted 1,252 shares of Common Stock at a price of $0.00 per share as an annual grant for non-employee directors.
Following this award, Bickley directly holds 31,609 shares of Crocs common stock. The footnote explains that this represents the annual common stock grant made under the company’s Board of Directors Compensation Plan, reflecting routine, compensation-related equity rather than an open-market purchase.
HUGHES CHARISSE FORD reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Charisse Ford Hughes received an equity award of 1,252 shares of common stock equivalent as compensation. The award is structured as restricted stock units granted at no cash cost per unit. After this grant, her direct holdings total 16,703 shares of Crocs common stock.
The RSUs vest upon the earlier of her separation from the Board of Directors or a change in control of Crocs. Each restricted stock unit represents the right to receive one share of common stock in the future, reflecting standard non-employee director compensation under the company’s Board of Directors Compensation Plan.
KAPLAN BETH J reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Beth J. Kaplan received an equity award of 1,252 shares of common stock as part of her annual compensation. The shares were granted at no cash cost to her and bring her directly held stake to 14,374 shares. The footnote explains this is the regular annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, indicating a routine, compensation-related transaction rather than an open-market trade.
REPLOGLE JOHN B reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director John B. Replogle received a stock-based compensation award of 1,252 shares of common stock on June 9, 2026. The shares were granted at no cash cost as the annual common stock grant to non-employee directors under the company’s Board of Directors Compensation Plan, and increased his direct holdings to 19,669 shares.
Crocs, Inc. director Neeraj Tolmare reported stock-based compensation awards rather than open-market trades. On 2026-06-09, he acquired 1,095 shares of common stock and 1,252 additional shares at a stated price of $0.00 per share.
The 1,095-share grant represents the annual common stock grant to non-employee directors under the Board of Directors Compensation Plan. The 1,252-share award reflects his election to receive restricted stock in lieu of the cash retainer for Board and committee service, with these restricted shares vesting in four equal quarterly installments from the issuance date.
Crocs, Inc. director Douglas J. Treff reported stock-based compensation awards rather than market trades. On June 9, 2026, he acquired 1,291 shares of Common Stock as part of the annual grant to non-employee directors and 1,252 shares of restricted stock elected in lieu of cash retainers under the Board of Directors Compensation Plan. These awards were granted at $0.00 per share as compensation, not open-market purchases, and left him holding tens of thousands of shares directly.
SMACH THOMAS J reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. director Thomas J. Smach received equity compensation in the form of common stock. He was granted 1,291 shares directly and 2,817 shares to a trust under the Board of Directors Compensation Plan, electing restricted stock instead of cash retainers. After these awards, he holds 90,249 shares directly and 111,063 shares indirectly via a trust, plus additional indirect holdings through his spouse and a child, with beneficial ownership of the child’s shares disclaimed except for any pecuniary interest.
Crocs, Inc. Chief Executive Officer Andrew Rees reported open-market sales of Crocs common stock on June 5, 2026 through the REES FAMILY LIVING TRUST, where he serves as trustee with voting and investment power. The trust sold a total of 32,688 shares in three blocks at weighted average prices of $116.9702, $117.9443, and $119.1099 per share, across multiple trades within narrow price ranges. Following these transactions, Rees continues to hold 475,789 shares directly, alongside his indirect holdings through the trust.
Crocs, Inc. director Ronald Frasch reported a charitable gift of company stock. On May 22, 2026, he donated 500 shares of Crocs common stock that he owned directly to a donor-advised fund for charitable purposes. After this gift, he continues to hold 74,928 shares of Crocs common stock directly.
Crocs, Inc. executive Terence Reilly reported a routine tax-related share disposition. On the reported date, 7,820 shares of Crocs common stock were withheld by the company at $100.14 per share to cover tax withholding obligations triggered by the vesting of a restricted stock unit award. This was not an open-market trade but an issuer withholding mechanism. After this non-market transaction, Reilly directly owned 104,531 shares of Crocs common stock.
Crocs, Inc. executive vice president and chief financial officer Patraic Reagan reported a routine tax-related share disposition. On this Form 4, 3,523 shares of common stock were withheld by the company to cover tax obligations when a restricted stock unit award vested. This was not an open-market sale. After the withholding, Reagan directly holds 86,071 shares of Crocs common stock.
Crocs, Inc. EVP & Crocs Brand President Anne Mehlman reported equity compensation and related adjustments. On March 10, 2026, she received grants of 44,222 and 24,122 restricted stock units under the 2020 Equity Incentive Plan, which vest between 2027 and 2029 based on continued employment and performance metrics.
The filing also shows 10,608 restricted stock units were cancelled because related performance goals were not achieved, and 3,010 shares of common stock were withheld at prices around $80 per share to cover tax obligations upon vesting. After these transactions, Mehlman directly holds 185,208 shares of Crocs common stock.
REAGAN PATRAIC reported acquisition or exercise transactions in this Form 4 filing.
Crocs, Inc. reported that EVP and Chief Financial Officer Patraic Reagan received a grant of 44,222 restricted stock units (RSUs) of common stock under the company’s 2020 Equity Incentive Plan. Following this award, he directly holds 89,594 shares or share-equivalents.
The award includes time-based and performance-based RSUs. 8,042 RSUs vest in three equal annual installments on March 10, 2027, 2028 and 2029. Up to 16,080 additional RSUs vest in three equal annual installments starting on a 2027 date when the compensation committee certifies that specified performance metrics are achieved. Up to 20,100 RSUs vest on a 2029 date when the committee certifies that further performance metrics are achieved, in each case subject to Reagan’s continued employment through the applicable vesting dates.
Crocs, Inc. executive vice president and chief brand officer Terence Reilly reported equity compensation changes. He received a grant of 44,222 restricted stock units (RSUs) under the 2020 Equity Incentive Plan, which vest in stages through performance and time-based conditions extending to 2029.
The filing also shows a disposition of 3,588 RSUs back to the issuer because related performance metrics were not achieved, and 1,691 shares of common stock were withheld at $80.40 per share to cover tax obligations upon RSU vesting. After these transactions, Reilly directly holds 112,351 shares of Crocs common stock.
Crocs, Inc. executive Rupert George Campbell, EVP and President of HEYDUDE, reported equity compensation and related adjustments in company stock. He received a grant of 38,695 restricted stock units (RSUs) under the 2020 Equity Incentive Plan, each representing one share of common stock, with vesting tied to future service and performance certification dates through 2029.
To cover tax withholding obligations upon RSU vesting, 987 shares at $82.91 and 564 shares at $80.40 were withheld by Crocs. In addition, 1,255 RSUs were cancelled because certain performance metrics for those awards were not achieved and the shares were returned to the issuer. After these transactions, Campbell directly holds 71,218 shares of Crocs common stock.
Crocs, Inc. chief executive Andrew Rees reported a large equity grant and related share adjustments. He received 207,853 restricted stock units under the 2020 Equity Incentive Plan, with portions vesting over time and additional tranches tied to future performance metrics and continued employment.
The filing also shows a disposition to the issuer of 55,419 shares linked to cancelled performance-based awards and a total of 13,954 shares withheld to cover tax obligations upon RSU vesting. After these transactions, Rees holds 475,789 shares directly and 775,981 shares indirectly through a family trust for which he has voting and investment power.
Crocs, Inc. Chief Executive Officer Andrew Rees reported a tax-related share disposition. On March 2, 2026, 3,956 shares of common stock were withheld by Crocs at $86.85 per share to satisfy tax obligations from vesting restricted stock units. After this, he directly held 337,309 shares and indirectly held 775,981 shares through a family trust for which he serves as trustee with voting and investment power.
Crocs, Inc. executive Anne Mehlman reported a tax-related share disposition. On the vesting of a restricted stock unit award, 630 shares of common stock were withheld by the company to cover tax obligations at a reference price of $86.85 per share.
After this tax-withholding disposition, Mehlman’s directly owned stake is reported as 130,482 shares of Crocs common stock.
Crocs, Inc. executive Anne Mehlman, EVP & Crocs Brand President, sold 12,145 shares of common stock in an open-market transaction on February 20, 2026, at a weighted average price of $100.0553 per share. After this sale, she directly owned 131,112 Crocs shares.
Crocs, Inc. director Thomas J. Smach reported that a family trust for which he serves as trustee sold 4,963 shares of Crocs common stock in an open-market transaction at a weighted average price of $100.00 per share, with individual sale prices ranging from $100.00 to $100.04.
After this sale, the trust holds 108,246 shares indirectly. Smach also holds 88,958 shares directly, while additional indirect holdings include 6,416 shares held by his spouse and 10,000 shares held in the name of his child, which he disclaims as beneficially owned except for any pecuniary interest.
Crocs, Inc. director Thomas J. Smach reported that a trust associated with his family sold 5,000 shares of Crocs common stock on February 13, 2026 in an open-market transaction at a weighted average price of $98.414 per share, with individual sale prices ranging from $98.190 to $98.955.
The shares sold were held in a family trust for the benefit of his children, and the filing states that Smach disclaims beneficial ownership of those securities except to the extent of his pecuniary interest. After this activity, the filing shows 88,958 shares held directly and additional indirect holdings through trusts, a child, and a spouse.
Crocs, Inc. executive Anne Mehlman reported routine equity award activity. On 02/01/2026, 1,501 shares of common stock were withheld by Crocs to cover tax obligations when a restricted stock unit award vested at $86.88 per share. On the same date, 19,839 restricted stock units were cancelled because the related performance goal was not met, recorded at $0. After these transactions, Mehlman directly held 143,257 shares of Crocs common stock.
Crocs, Inc. (CROX) reported an insider equity transfer and gift by a director and Chief Executive Officer. On 11/20/2025, the reporting person gifted 40,000 shares of Crocs common stock that were indirectly owned, at a stated price of $0, indicating a charitable or other non-sale transfer. After this transaction, the reporting person beneficially owns 775,981 shares indirectly and 341,265 shares directly.
The filing explains that 736,233 shares previously held directly by the reporting person were transferred to the REES FAMILY LIVING TRUST U/A DTD 03/22/2019. The reporting person serves as trustee of this trust and exercises voting and investment power over the shares it beneficially owns, so overall economic exposure is largely maintained but held in a different ownership structure.
Crocs, Inc. (CROX) disclosed an insider purchase on Form 4. A director bought 3,000 shares of common stock on 11/11/2025 at $74.50 per share (transaction code P). After the transaction, the director beneficially owns 18,417 shares, held directly.
Insider grant of restricted stock units to Crocs CFO. The filing shows that Reagan Patraic, EVP and Chief Financial Officer of Crocs, Inc. (CROX), was granted 45,372 restricted stock units under the companys 2020 Equity Incentive Plan on 09/22/2025. Each unit represents the right to one share of common stock and vests in five installments: 21.43% on 03/22/2026, 21.43% on 09/22/2026, 21.43% on 03/22/2027, 21.43% on 09/22/2027, and 14.28% on 09/22/2028, contingent on continued employment.